Changes in acute viral hepatitis epidemiology in the Turkish adult population: A multicenter study

Karacaer, Zehra; Tosun, Selma; Batırel, Ayşe; Şahin, Suzan; Altas, Irem; Uysal, Serhat; Erol, Serpil; Ceran, Nurgül; Albayrak, Aynur; Yıldız, İlknur Esen; Kostakoğlu, Uğur; Kacar, Fatma; Kuzhan, Nuretdin; Kadanalı, Ayten; Karagöz, Gül; Yeni̇lmez, Ercan; Turan, Derya Bayırlı; Yıldırım, Arzu Altunçekiç; Koçak, Funda; Çeti̇nkaya, Rıza Aytaç; Parlak, Mehmet; Aydın, Özlem Altuntaş; Ergen, Pınar; Durmuş, Gül; Kaygusuz, Türkkan Öztürk; Dagli, Ozgur; Demir, Canan; Karadağ, Fatma Yılmaz

doi:10.5152/tjg.2018.17431

Cited by 6 publications

(4 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In this context, the frequency of acute HAV infection in our area is consistent with the studies from Turkey. Similar to our study, Karacaer et al reported that the incidence of acute HAV infection was higher especially in adolescence in which included 17 centers' data for the epidemiology of acute viral hepatitis (34). Çeviker et al determined that complications due to acute hepatitis A were observed more frequently in adult ages (35).…”

Section: Discussionsupporting

confidence: 87%

Seroprevalence of Hepatitis A virus according to age groups in Northern Anatolia of Turkey

Düzenli¹

2022

Akademik Gastroenteroloji Dergisi

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 87%

Seroprevalence of Hepatitis A virus according to age groups in Northern Anatolia of Turkey

Düzenli¹

2022

Akademik Gastroenteroloji Dergisi

View full text Add to dashboard Cite

show abstract

“…The incidence of acute HB below 1/100,000 recorded in 2016 represents the lowest value since the mandatory notification of acute HB was introduced in APV [10]. A similar trend of acute HB incidence rates was registered in Serbia (1.77/100,000) and, to a three-fold lower extent, in the European Union (≈0.6/100,000) [41][42][43][44]. Compared to acute HB, the incidence of chronic HB in APV was several times higher (3.7/100,000 in 2017) [10], which can be considered as a reflection of the unfavorable epidemiological situation and the lack of universal HB vaccination in the past.…”

Section: Discussionmentioning

confidence: 75%

Seroprevalence Study of Anti-HBs Antibodies in the General Population of Vojvodina, Serbia

Rajčević,

Medić,

Patić

et al. 2024

Medicina

View full text Add to dashboard Cite

Background and Objectives: Hepatitis B (HB) is a major global health problem and a potentially life-threatening disease caused by the hepatitis B virus (HBV). Also, it is an important cause of morbidity and mortality worldwide. Thanks to serological surveys, testing hepatitis B surface antibodies (anti-HBs) allows for serological assessments of their prevalence. The presence of anti-HBs, which protects against HBV infection, can be attributed to HB vaccination or natural HBV infection. The aim of our study was to evaluate the prevalence of HB surface antibodies (anti-HBs) as an indicator of collective immunity against HBV in the general population of the Autonomous Province of Vojvodina, Serbia. In addition, to distinguish whether anti-HBs were induced by the vaccine or by infection, the presence of antibodies against the hepatitis B core antigen (anti-HBc) was tested among those who were anti-HBs-positive. Materials and Methods: A total of 3467 residual sera samples, collected according to the specifications of the European Sero-Epidemiology Network 2 (ESEN2) study, from April 2015 to March 2016, were screened for the presence of anti-HBs using a chemiluminescence immunoassay. The difference between categorical variables was tested using the chi-square test. Results: Overall, 1870 (53.9%, 95% CI: 52.3–55.6) participants tested positive for anti-HBs. The median age of the study participants was 17 years (IQR 9–35). The anti-HB seroprevalence decreased with age, ranging from 80.7% (95% CI: 78.9–82.4) in the 1–19-year-old group to 16.4% (95% CI: 12.0–20.9) in the ≥60 years’ age group. A total of 71 (3.8%, 95% CI: 2.9–4.7) serum samples were also anti-HBc-positive. Higher prevalence, but not statistically significant, was noticed in women (4.1%, 95% CI: 2.8–5.4) compared with men (3.5, 95% CI: 2.4–4.8) (p = 0.542). Also, there was a significant difference across the age groups, where those ≥60 years old had a prevalence of 65.9% (95% CI: 51.9–79.9) and the age category of 1–19-year-olds had just 0.2% (95% CI: 0.0–0.4) (p < 0.001). Conclusions: This study provides a comprehensive assessment of the anti-HBs seroprevalence of the general population in Vojvodina and provides an opportunity to better shape the national preventive strategy related to HBV.

show abstract

“…In a very interesting multicenter study conducted in Turkey, Karacaer et al (1) reported on changes in acute viral hepatitis epidemiology in the adult population. The most commonly found microorganisms were hepatitis B virus (55.2%) and hepatitis A virus (HAV) (37.6%), and types of acute viral hepatitis significantly differed according to the age group.…”

Section: Dear Editormentioning

confidence: 99%

Comment on “Changes in acute viral hepatitis epidemiology in the Turkish adult population: A multicenter study”

Caviglia

Fagoonee

2018

Turk J Gastroenterol

View full text Add to dashboard Cite

Changes in acute viral hepatitis epidemiology in the Turkish adult population: A multicenter study

Abstract: ABSTRACT

Cited by 6 publications

References 12 publications

Seroprevalence of Hepatitis A virus according to age groups in Northern Anatolia of Turkey

Seroprevalence of Hepatitis A virus according to age groups in Northern Anatolia of Turkey

Seroprevalence Study of Anti-HBs Antibodies in the General Population of Vojvodina, Serbia

Comment on “Changes in acute viral hepatitis epidemiology in the Turkish adult population: A multicenter study”

Contact Info

Product

Resources

About